Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, MRECIST, and Others

Overview

Journal J Gastrointest Cancer

Publisher Springer

Specialties Gastroenterology
Oncology

Date 2017 Jun 19

PMID 28624974

Citations 5

Authors

Mecit Kantarci

Berhan Pirimoglu

Affiliations

Soon will be listed here.

Citing Articles

Assessment of the response to systemic treatment of colorectal liver metastases on cross-sectional imaging - a systematic review.

Morawska I, Cieszanowski A Pol J Radiol. 2023; 88:e512.

PMID: 38125815 PMC: 10731444. DOI: 10.5114/pjr.2023.132884.

Study on the changes of CT texture parameters before and after HCC treatment in the efficacy evaluation and survival predication of patients with HCC.

Zhou W, Lv Y, Hu X, Luo Y, Li J, Zhu H Front Oncol. 2022; 12:957737.

PMID: 36387217 PMC: 9650244. DOI: 10.3389/fonc.2022.957737.

Objective response rate assessment in oncology: Current situation and future expectations.

Aykan N, Ozatli T World J Clin Oncol. 2020; 11(2):53-73.

PMID: 32133275 PMC: 7046919. DOI: 10.5306/wjco.v11.i2.53.

Implications of Immunotherapy in Hepatobiliary Tumors.

Gottlieb A, Best J, Canbay A Visc Med. 2019; 35(1):18-26.

PMID: 31312646 PMC: 6597927. DOI: 10.1159/000496755.

Large hepatocellular carcinoma with local remnants after transarterial chemoembolization: treatment by sorafenib combined with radiofrequency ablation or sorafenib alone.

Yuan H, Lan Y, Li X, Tang J, Liu F Am J Cancer Res. 2019; 9(4):791-799.

PMID: 31106004 PMC: 6511642.

References

Zaidi H, Mawlawi O, Orton C . Point/counterpoint. Simultaneous PET/MR will replace PET/CT as the molecular multimodality imaging platform of choice. Med Phys. 2007; 34(5):1525-8. DOI: 10.1118/1.2732493. View

Jiang R, Jiang J, Zhao L, Zhang J, Zhang S, Yao Y . Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation. Oncotarget. 2015; 6(39):42380-93. PMC: 4747234. DOI: 10.18632/oncotarget.5675. View

Park Y, Lee C, Kim J, Kim I, Kiefer B, Seo T . Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. Magn Reson Imaging. 2014; 32(6):638-46. DOI: 10.1016/j.mri.2014.03.003. View

Nishino M, Jackman D, Hatabu H, Yeap B, Cioffredi L, Yap J . New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. AJR Am J Roentgenol. 2010; 195(3):W221-8. PMC: 3130298. DOI: 10.2214/AJR.09.3928. View

Chen X, Xiao E, Shu D, Yang C, Liang B, He Z . Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging. Eur J Gastroenterol Hepatol. 2013; 26(1):109-13. DOI: 10.1097/MEG.0b013e328363716e. View

Zhu A, Duda D, Sahani D, Jain R . HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol. 2011; 8(5):292-301. PMC: 3266719. DOI: 10.1038/nrclinonc.2011.30. View

Watanabe H, Kanematsu M, Goshima S, Kajita K, Kawada H, Noda Y . Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T. Acta Radiol. 2013; 55(10):1166-73. DOI: 10.1177/0284185113514966. View

Okada M, Kim T, Murakami T . Hepatocellular nodules in liver cirrhosis: state of the art CT evaluation (perfusion CT/volume helical shuttle scan/dual-energy CT, etc.). Abdom Imaging. 2011; 36(3):273-81. DOI: 10.1007/s00261-011-9684-2. View

Yuan L, Sun M, Chen Y, Long M, Zhao X, Yin J . Non-Gaussian diffusion alterations on diffusion kurtosis imaging in patients with early Alzheimer's disease. Neurosci Lett. 2016; 616:11-8. DOI: 10.1016/j.neulet.2016.01.021. View

10.

Pirimoglu B, Sade R, Ogul H, Kantarci M, Eren S, Levent A . How Can New Imaging Modalities Help in the Practice of Radiology?. Eurasian J Med. 2017; 48(3):213-221. PMC: 5268606. DOI: 10.5152/eajm.2016.0260. View

11.

Kuo Y, Li C, Chen C, Jao J, Wu D, Liu G . In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging. 2004; 19(5):598-604. DOI: 10.1002/jmri.20046. View

12.

Martin Noguerol T, Sanchez-Gonzalez J, Barbero J, Garcia-Figueiras R, Baleato-Gonzalez S, Luna A . Clinical Imaging of Tumor Metabolism with ¹H Magnetic Resonance Spectroscopy. Magn Reson Imaging Clin N Am. 2015; 24(1):57-86. DOI: 10.1016/j.mric.2015.09.002. View

13.

Ogul H, Bayraktutan U, Kizrak Y, Pirimoglu B, Yuceler Z, Sagsoz M . Abdominal perfusion computed tomography. Eurasian J Med. 2015; 45(1):50-7. PMC: 4261507. DOI: 10.5152/eajm.2013.09. View

14.

Dijkstra H, Baron P, Kappert P, Oudkerk M, Sijens P . Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol. 2011; 22(4):891-9. PMC: 3297749. DOI: 10.1007/s00330-011-2313-1. View

15.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

16.

Yu J, Kim J, Chung J, Kim K . Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. J Magn Reson Imaging. 2009; 30(1):153-60. DOI: 10.1002/jmri.21818. View

17.

Mehdizade A, Somon T, Wetzel S, Kelekis A, Martin J, Scheidegger J . Diffusion weighted MR imaging on a low-field open magnet. Comparison with findings at 1.5T in 18 patients with cerebral ischemia. J Neuroradiol. 2003; 30(1):25-30. View

18.

Kan Z, Kobayashi S, Phongkitkarun S, Charnsangavej C . Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model. Radiology. 2005; 237(1):144-50. DOI: 10.1148/radiol.2371040526. View

19.

Penner A, Sprinkart A, Kukuk G, Gutgemann I, Gieseke J, Schild H . Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI. Eur Radiol. 2013; 23(10):2773-83. DOI: 10.1007/s00330-013-2869-z. View

20.

Llovet J, Bruix J . Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008; 48(4):1312-27. PMC: 2597642. DOI: 10.1002/hep.22506. View